This clinical trial examines the effectiveness of the teach-back method on patient satisfaction and adherence to wound care regimen after Mohs micrographic surgery. The teach-back method is delivered using the ask-tell-ask method. Investigators ask the patient about their knowledge of wound care healing, provide the patient in person education on wound care, then ask the patient to repeat what was said. If the answer is wrong or incomplete, the researcher will go over the information again with the patient to clear up any misunderstandings. This study may help examine different way to educate patients about taking care of their wound and see how this method affects patient satisfaction, compliance to the wound care regimen, and patient experience.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT04377971.
PRIMARY OBJECTIVE:
I. To determine whether study participants who have received the teach-back method have an increase in wound care adherence compared to those who received the standard of care 1 week post-operatively.
SECONDARY OBJECTIVES:
I. To characterize differences in the patient experience at 2 weeks post-operatively.
II. To quantify and characterize phone calls made post-operatively, up to 2 weeks after surgery.
III. To characterize the differences in patient wound care compliance between the two interventional groups at 2 weeks after surgery.
IV. To characterize the differences in additional aspects of wound care compliance between the two interventional groups at 2 weeks after surgery (emergency room [ER] visits, bleeding, etc.).
V. To quantify the incidence of complications 2 weeks after surgery.
OUTLINE: Patients are randomized to 1 of 2 groups.
GROUP I: Patients undergo Mohs surgery for skin cancer as scheduled. After surgery, patients receive teach-back method for patient education.
GROUP II: Patients undergo Mohs surgery for skin cancer as scheduled. After surgery, patients receive standard of cared wound education.
After completion of study, patients are followed up at 1 and 2 week post-operatively.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationCase Comprehensive Cancer Center
Principal InvestigatorChristina Wong
